Germany Diabetes Care Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Blood glucose monitoring devices and Insulin delivery devices), By End Use (Hospital, Ambulatory surgical centers, Diagnostic centres, Homecare, and Others), and Germany Diabetes Care Devices Market Insights, Industry Trend, Forecasts to 2033

Germany Diabetes Care Devices Market Insights Forecasts to 2033

• The Germany Diabetes Care Devices Market Size was valued at USD 2.11 Billion in 2023.
• The Germany Diabetes Care Devices Market Size is Growing at a CAGR of 5.63% From 2023 to 2033
• The Germany Diabetes Care Devices Market Size is Expected to Exceed USD 3.65 Billion By 2033

The Germany Diabetes Care Devices Market Size is Anticipated to Exceed USD 3.65 Billion By 2033, Growing at a CAGR of 5.63% From 2023 to 2033. The increasing prevalence of diabetes, technological advancement in diabetes care devices, and investment by public and private organizations for diabetes care are driving the diabetes care devices market in the Germany.     

Market Overview

Diabetes care devices market refers to the medical devices used for managing and treating diabetes. These medical devices include blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, and related accessories, but excluding pharmaceutical treatments like insulin and oral medications. Diabetes care devices are the technologies that help individuals manage their blood glucose levels, such as blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, and smart insulin pens, among others. There is a significant shift towards the advancement in digital solutions, enhancing patient engagement and improving health outcomes. There are growing technological advancements and the introduction of advanced insulin pumps and pens. Further, the significant contribution of companies to technological advancements and creating advanced products are promoting market growth opportunities.

Report Coverage

This research report categorizes the market for the Germany diabetes care devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany diabetes care devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Germany diabetes care devices market.

Driving Factors

The increasing prevalence of diabetes in the country is propelling the diabetes care devices market. It was estimated that 5.8 million persons with type 2 diabetes are living in Germany. The technological advancement in diabetes care devices which includes continuous glucose monitors (CGMs), smart insulin pens, and automated insulin delivery systems (AID) for improving diabetes management and reduction of insulin treatment burden is driving the market growth. The investment by public and private organizations for diabetes care is significantly contributing to propel the market. For instance, the German Center for Diabetes Research (DZD) and private companies including Abbott, Roche, and Medtronic drive innovation in diabetes technology and devices.

Restraining Factors

The increased cost of diabetes care devices and rigorous regulatory framework are challenging the market for diabetes care devices.

Market Segmentation

The Germany diabetes care devices market share is classified into product and end use.

• The blood glucose monitoring devices segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR growth during the projected timeframe.

Based on the product, the Germany diabetes care devices market is divided into blood glucose monitoring devices and insulin delivery devices. Among these, the blood glucose monitoring devices segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR growth during the projected timeframe. The significance of these devices in both patients and healthcare professionals in identifying elevated or reduced blood glucose levels is contributing to propelling the market.

• The hospital segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR growth during the projected timeframe.

Based on the end use, the Germany diabetes care devices market is divided into hospital, ambulatory surgical centers, diagnostic centres, homecare, and others. Among these, the hospital segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR growth during the projected timeframe. Diabetes care devices aid in the safe and effective management of diabetes in both inpatient and outpatient settings. The use of devices such as glucometers, CGMs, and automated insulin delivery systems is propelling the market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany diabetes care devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Diabetes Care
• Roche
• LifeScan
• Dexcom
• Medtronic
• ARKRAY Inc.
• Ascensia Diabetes Care
• AgaMatrix
• Bionime Corporation
• Novo Nordisk
• Eli Lilly
• Sanofi
• Rossmax International Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In October 2022, Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed 770G system. Using an individual's data, My Insights relies on the power of data science to provide personalized tips, trends, and reminders that customers can use to help with their diabetes management goals.

• In April 2022, Abbott, CamDiab and Ypsomed announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes.  

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Germany diabetes care devices Market based on the below-mentioned segments:

Germany Diabetes Care Devices Market, By Product

• Blood glucose monitoring devices
• Insulin delivery devices

Germany Diabetes Care Devices Market, By End Use

• Hospital
• Ambulatory surgical centers
• Diagnostic centres
• Homecare
• Others